The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation
Clinical trial NCT07441967 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07441967
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-20
- Primary completion
- 2027-12-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.